• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Friday, March 24, 2023

    Time

    2:00 PM - 3:00 PM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      Pharmacists and technicians face many legal and regulatory issues when dispensing prescriptions, besides the risk of making an error. Federal and state legislative and regulatory bodies and courts have made changes that impact prescribing and dispensing, especially for controlled drugs. Pharmacy staff need to be cognizant of penalties for excessive prescribing and dispensing of opioids, new standards for determining the validity of a prescription, oversight of information about medically controversial therapies, and limits on dispensing of politically divisive drugs.


      Handouts

      Slide Document 23039L03_2pp.pdf
      Slide Document 23039L03_6pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      Describe penalties for overprescribing or dispensing controlled substances
      Discuss the recent Supreme Court decision concerning the overprescribing of controlled drugs
      Compare the application of legal and regulatory rules when disseminating information about controversial therapies
      Characterize emerging legal and regulatory standards on refusing or preventing dispensing

      Pharmacy Technician

      Describe penalties for overprescribing or dispensing controlled substances
      Discuss the recent Supreme Court decision concerning the overprescribing of controlled drugs
      Compare the application of legal and regulatory rules when disseminating information about controversial therapies
      Characterize emerging legal and regulatory standards on refusing or preventing dispensing

      Nurse

      Describe penalties for overprescribing or dispensing controlled substances
      Discuss the recent Supreme Court decision concerning the overprescribing of controlled drugs
      Compare the application of legal and regulatory rules when disseminating information about controversial therapies
      Characterize emerging legal and regulatory standards on refusing or preventing dispensing
    • Repeat Presentation

      This presentation was last given on 9/28/2023 5:00 PM

      Future Airings

      Date Time
      Tuesday, April 18, 2023 10:30 AM View
      Wednesday, May 10, 2023 10:30 AM View
      Thursday, June 15, 2023 10:30 AM View
      Thursday, July 27, 2023 10:30 AM View
      Thursday, September 28, 2023 5:00 PM View

    • Activity Type

      Knowledge

      CE Broker

      20-985962

      Universal Activity Number

      Pharmacist 0798-0000-23-039-L03-P

      Pharmacy Technician 0798-0000-23-039-L03-T

      Nurse 0798-0000-23-039-L03-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.